id: telemedicine_use_to_hypertension_control_140_90
name: Telemedicine Use â†’ Hypertension Control
from_node:
  node_id: telemedicine_use
  node_name: Telemedicine Use
to_node:
  node_id: hypertension_control_140_90
  node_name: Hypertension Control
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Telemedicine enables remote communication and interaction between healthcare
  providers and patients with hypertension'
- 'Step 2: Increased accessibility facilitates more frequent monitoring of blood pressure
  and medication adherence'
- 'Step 3: Enhanced patient engagement and self-efficacy support sustained disease
  management behaviors'
- 'Step 4: Continuous remote support and individualized care lead to improved blood
  pressure control outcomes'
evidence:
  quality_rating: B
  n_studies: 4
  primary_citation: 'Wenhang Zhang et al. 2020. Effect of Telemedicine on Quality
    of Care in Patients with Coexisting Hypertension and Diabetes: A Systematic Review
    and Meta-Analysis. Telemedicine journal and e-health.'
  supporting_citations: []
description: Telemedicine significantly improves blood pressure control in patients
  with hypertension. Meta-analysis of clinical trials found telemedicine reduced systolic
  blood pressure by 10.4 mmHg and diastolic blood pressure by 4.8 mmHg. The mechanism
  operates through enhanced patient-provider communication, improved blood pressure
  monitoring, increased medication adherence, and better patient engagement and self-efficacy.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 10.4
    type: mean_difference_mmHg_systolic
    ci_lower: null
    ci_upper: null
  p_value: null
  sample_size: null
moderators:
- name: intervention_duration
  direction: strengthens
  strength: moderate
  description: Intervention durations ranged from 3 to 6 months; longer-term studies
    needed to confirm sustainability
- name: comorbid_diabetes
  direction: strengthens
  strength: moderate
  description: Study focused on patients with coexisting hypertension and diabetes,
    who face greater disease management challenges
